Real World Efficacy of Luspatercept in Patients with Lower-risk Myelodysplastic Syndromes/Neoplasms (LR-MDS); a Single Center Study in a Heavily Pretreated Cohort
Kometas, Marisa, Hyak, Jonathan, Hoff, Fieke, Irizarry-Gatell, Vivian, Marinos, Alejandro, Jackson, Clayton, Anderson, Julia, Kalkan, Fatma, Ramakrishnan, Praveen, Afrough, Aimaz, Wolfe, Heather, Khan, Adeel, Anderson, Larry, Awan, Farrukh, Kaur, Gurbakhash, Yilmaz, Elif, Alvarenga, Julio, Chen, Weina, Weinberg, Olga, Cantu, Miguel, Collins, Robert H., Chung, Stephen S., Madanat, Yazan F.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
MDS-199 Real World Efficacy of Luspatercept in Patients with Lower-risk Myelodysplastic Syndromes/Neoplasms (LR-MDS); a Single Center Study in a Heavily Pretreated Cohort
Kometas, Marisa, Hyak, Jonathan, Hoff, Fieke, Irizarry-Gatell, Vivian, Marinos, Alejandro, Jackson, Clayton, Anderson, Julia, Kalkan, Fatma, Ramakrishnan, Praveen, Afrough, Aimaz, Wolfe, Heather, Khan, Adeel, Anderson, Larry, Awan, Farrukh, Kaur, Gurbakhash, Yilmaz, Elif, Alvarenga, Julio, Chen, Weina, Weinberg, Olga, Cantu, Miguel, Collins, Robert H., Chung, Stephen S., Madanat, Yazan F.
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article